Joseph Todisco, SVP, Specialty Commercial at Amneal Pharmaceuticals, Inc. (AMRX), bought 15,000 shares at $9.88 ($148K) on 2019-05-13, disclosed to the SEC on 2019-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CRMD | BUY | 2024-03-14 | $101K | — | Filing → |
| CRMD | BUY | 2023-09-08 | $37K | — | Filing → |
| CRMD | BUY | 2022-11-16 | $76K | — | Filing → |